Common Contracts
2 similar Master Development and License Agreement contracts by Elite Pharmaceuticals Inc /Nv/
MASTER DEVELOPMENT AND LICENSE AGREEMENT FOR PRODUCTS BETWEEN ELITE PHARMACEUTICALS, INC. AND SUNGENMaster Development and License Agreement • August 9th, 2017 • Elite Pharmaceuticals Inc /Nv/ • Pharmaceutical preparations • New Jersey
This DEVELOPMENT AND LICENSE AGREEMENT (the “Agreement”), dated July 6, 2017 (the “Effective Date”) between SunGen Pharma LLC, 303C College Road East, Princeton, NJ 08540, USA (SunGen) and Elite Laboratories, Inc. (a subsidiary of Elite Pharmaceuticals, Inc.), organized under the laws of the State of Delaware, with offices at 165 Ludlow Avenue, Northvale, New Jersey, USA (“Elite”); SunGen and Elite may sometimes hereinafter be referred to as a “Party” or collectively as the “Parties”.
MASTER DEVELOPMENT AND LICENSE AGREEMENT FOR PRODUCTS BETWEEN ELITE PHARMACEUTICALS, INC. AND SUNGENMaster Development and License Agreement • November 9th, 2016 • Elite Pharmaceuticals Inc /Nv/ • Pharmaceutical preparations • New Jersey
This DEVELOPMENT AND LICENSE AGREEMENT (the “Agreement”), dated August 24, 2016 (the “Effective Date”) between SunGen Pharma LLC, CCIT Lab 124, 675 US Highway One, North Brunswick, NJ 08902, USA (SunGen) and Elite Laboratories, Inc. (a subsidiary of Elite Pharmaceuticals, Inc.), organized under the laws of the State of Delaware, with offices at 165 Ludlow Avenue, Northvale, New Jersey, USA (“Elite”); SunGen and Elite may sometimes hereinafter be referred to as a “Party” or collectively as the “Parties”.
